SunHydrogen, Inc., the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, has shared an update on the Company’s progress toward demonstrating its green hydrogen panels at the commercially-relevant 1m² scale.

For the biopharma industry to match the pace of genomic innovations and speed new therapies to market, it will need to embrace innovative collaborations.

Perspective Therapeutics, Inc. has celebrating the first shipment and patient dosing from its second manufacturing facility for the production of its 203Pb- and 212Pb-labeled radiopharmaceuticals.

SunHydrogen, Inc. has announced the appointment of David Raney to the SunHydrogen Board of Directors.

SunHydrogen has joined the Texas Hydrogen Alliance, a coalition of industry leaders dedicated to advancing the hydrogen economy in Texas.

Integrated DNA Technologies has announced the expansion of its Archer™ next generation sequencing (NGS) assay solutions portfolio with the new Archer VARIANTPlex™ Lymphoma panel.